Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 38 results.
User Information
Export Records
  1. 1.   Novel Arf1 Inhibitors Drive Cancer Stem Cell Aging and Potentiate Anti-Tumor Immunity
  2. Wang, Yuetong; Li, Qiaoming; Ding, Yahui; Luo, Chenfei; Yang, Jun; Wang, Na; Jiang, Ning; Yao, Tiange; Wang, Guohao; Shi, Guoming; Hou, Steven X
  3. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2024, Sep 03; e2404442.
  1. 2.   Cancer stem cells as the source of tumor associated myoepithelial cells in the tumor microenvironment developing ductal carcinoma in situ
  2. Afify, Said M; Hassan, Ghmkin; Zahra, Maram H; Nawara, Hend M; Abu Quora, Hagar A; Osman, Amira; Mansour, Hager; Kumon, Kazuki; Seno, Akimasa; Chen, Ling; Satoh, Ayano; Salomon,David; Seno, Masaharu
  3. Biomaterials. 2023, Jul 20; 301: 122249.
  1. 3.   GSK-3a/ß and MEK inhibitors assist the microenvironment of tumor initiation
  2. Hassan, Ghmkin; Afify, Said M; Zahra, Maram H; Nawara, Hend M; Kumon, Kazuki; Iwasaki, Yoshiaki; Salomon,David; Seno, Akimasa; Seno, Masaharu
  3. Cytotechnology. 2023, Jun; 75(3): 243-253.
  1. 4.   Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma
  2. Golino, Jihye L; Wang, Xin; Bian, Jing; Ruf, Benjamin; Kelly, Michael; Karim,Baktiar; Cam, Maggie C; Xie, Changqing
  3. Cancers. 2023, Apr 25; 15(9):
  1. 5.   Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture
  2. Wojcik, Heather M; Lovvorn, Harold N; Hollingshead,Melinda; Pierce, Janene; Stotler,Howard; Murphy, Andrew J; Borgel,Suzanne; Phelps, Hannah M; Correa, Hernan; Perantoni,Alan
  3. Frontiers in Oncology. 2023, Mar 16; 13: 1091274.
  1. 6.   Aminoflavone upregulates putative tumor suppressor miR-125b-2-3p to inhibit luminal A breast cancer stem cell-like properties
  2. Mavingire, Nicole; Campbell,Petreena; Liu, Tiantian; Wooten, Jonathan; Khan, Salma; Chen, Xin; Matthews, Jason; Wang, Charles; Brantley, Eileen
  3. Precision Clinical Medicine. 2022, Jun; 5(2): pbac008.
  1. 7.   Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways
  2. Hassan, Ghmkin; Ohara, Toshiaki; Afify, Said M.; Kumon, Kazuki; Zahra, Maram H.; Fu, Xiaoying; Al Kadi, Mohamad; Seno, Akimasa; Salomon,David; Seno, Masaharu
  3. Journal of Experimental & Clinical Cancer Research. 2022, Jan 21; 41(1):
  1. 8.   A Covalent Calmodulin Inhibitor as a Tool to Study Cellular Mechanisms of K-Ras-Driven Stemness
  2. Okutachi, Sunday; Manoharan, Ganesh Babu; Kiriazis, Alexandros; Laurini, Christina; Catillon, Marie; McCormick, Frank; Yli-Kauhaluoma, Jari; Abankwa, Daniel
  3. Frontiers in cell and developmental biology. 2021, Jul 8; 9: 665673.
  1. 9.   Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
  2. Ishii, Hiroko; Afify, Said M.; Hassan, Ghmkin; Salomon,David; Seno, Masaharu
  3. Cancers. 2021, May; 13(10):
  1. 10.   Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia
  2. Winn, Blake A; Devkota, Laxman; Kuch, Bunnarack; MacDonough, Matthew T; Strecker, Tracy E; Wang, Yifan; Shi, Zhe; Gerberich, Jeni L; Mondal, Deboprosad; Ramirez, Alejandro J; Hamel,Ernest; Chaplin, David J; Davis, Peter; Mason, Ralph P; Trawick, Mary Lynn; Pinney, Kevin G
  3. Journal of natural products. 2020, APR 24; 83(4): 937-954.
  1. 11.   Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A
  2. Waheed, Sana; Cheng, Robert Ys; Casablanca, Yovanni; Maxwell, G Larry; Wink,David; Syed, Viqar
  3. Molecules (Basel, Switzerland). 2019, Oct 16; 24(20): pii: E3722..
  1. 12.   Glypican-3-Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma
  2. Fu, Ying; Urban, Daniel J.; Nani, Roger R.; Zhang, Yi-Fan; Li, Nan; Fu, Haiying; Shah, Hamzah; Gorka, Alexander P.; Guha, Rajarshi; Chen, Lu; Hall, Matthew D.; Schnermann,Martin; Ho, Mitchell
  3. Hepatology (Baltimore, Md.). 2019, AUG; 70(2): 563-576.
  1. 13.   Role of nitric oxide in pancreatic cancer cells exhibiting the invasive phenotype
  2. Fujita, Mayumi; Somasundaram,Veena; Basudhar,Debashree; Cheng,Robert; Ridnour,Lisa; Higuchi, Harumi; Imadome, Kaori; No, Jae Hong; Bharadwaj, Gaurav; Wink,David
  3. REDOX BIOLOGY. 2019, Apr; 22
  1. 14.   Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model
  2. Alam, Md Jahangir; Takahashi, Ryota; Afify, Said M.; Oo, Aung Ko Ko; Kumon, Kazuki; Nawara, Hend M.; Khayrani, Aprilliana Cahya; Du, Juan; Zahra, Maram H.; Seno, Akimasa; Salomon, David; Seno, Masaharu
  3. International journal of molecular sciences. 2018, NOV; 19(11):
  1. 15.   Single cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
  2. Zheng, Hongping; Pomyen, Yotsawat; Hernandez, Maria Olga; Li, Caiyi; Livak, Ferenc; Tang, Wei; Dang, Hien; Greten, Tim F; Davis, Jeremy; Zhao, Yongmei; Mehta, Monika; Levin, Yelena; Shetty, Jyoti; Tran, Bao; Budhu, Anuradha; Wang, Xin Wei
  3. Hepatology. 2018, Jul; 68(1): 127-140.
  1. 16.   PML: Regulation and multifaceted function beyond tumor suppression
  2. Hsu, Kuo-Sheng; Kao, Hung-Ying
  3. Cell and Bioscience. 2018, Jan 25; 8: 5.
  1. 17.   Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma
  2. Liu, Qiang; Cui, Xiang; Yu, Xi; Bian, Bai-Shi-Jiao; Qian, Feng; Hu, Xu-Gang; Ji, Cheng-Dong; Yang, Lang; Ren, Yong; Cui, Wei; Zhang, Xia; Zhang, Peng; Wang, Jiming; Cui, You-Hong; Bian, Xiu-Wu
  3. MOLECULAR CANCER. 2017, Apr 21; 16(1): 81.
  1. 18.   Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells
  2. Reshma, R. S.; Sreelatha, K. H.; Somasundaram, V.; Satheesh Kumar, S.; Nadhan, R.; Nair, R. S.; Srinivas, P.
  3. Pharmacological Research. 2016, Mar; 105: 134-45.
  1. 19.   An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients
  2. Crea, F.; Fornaro, L.; Paolicchi, E.; Masi, G.; Frumento, P.; Loupakis, F.; Salvatore, L.; Cremolini, C.; Schirripa, M.; Graziano, F.; Ronzoni, M.; Ricci, V.; Farrar, W. L.; Falcone, A.; Danesi, R.
  3. Annals of Oncology. 2012, May; 23(5): 1207-1213.
  1. 20.   The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres
  2. Cabarcas, S. M.; Thomas, S.; Zhang, X. H.; Cherry, J. M.; Sebastian, T.; Yerramilli, S.; Lader, E.; Farrar, W. L.; Hurt, E. M.
  3. Genomics. 2012, Feb; 99(2): 108-117.
  1. 21.   Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells
  2. Yao, X. H.; Liu, Y.; Chen, K. Q.; Gong, W. H.; Liu, M. Y.; Bian, X. W.; Wang, J. M.
  3. International Immunopharmacology. 2011, Dec; 11(12): 1961-1966.
  1. 22.   The cancer stem cell niche-there goes the neighborhood?
  2. Cabarcas, S. M.; Mathews, L. A.; Farrar, W. L.
  3. International Journal of Cancer. 2011, Nov; 129(10): 2315-2327.
  1. 23.   The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling
  2. Ping, Y. F.; Yao, X. H.; Jiang, J. Y.; Zhao, L. T.; Yu, S. C.; Jiang, T.; Lin, M. C. M.; Chen, J. H.; Wang, B.; Zhang, R.; Cui, Y. H.; Qian, C.; Wang, J. M.; Bian, X. W.
  3. Journal of Pathology. 2011, Jul; 224(3): 344-354.
  1. 24.   DNA repair: the culprit for tumor-initiating cell survival?
  2. Mathews, L. A.; Cabarcas, S. M.; Farrar, W. L.
  3. Cancer and Metastasis Reviews. 2011, Jun; 30(2): 185-197.
  1. 25.   Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy
  2. Barsov, E. V.
  3. Immunotherapy. 2011, Mar; 3(3): 407-421.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel